Autologous Dendritic Cell therapy(PT. JES Kasih Nusantara Sejahterah)

N/A

Report date: 2025/03/11 20:00:09

Base Information

Drug NameAutologous Dendritic Cell therapy(PT. JES Kasih Nusantara Sejahterah)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy

Mechanisms of ActionDendritic cells modulators

TargetsNot applicable

Therapy Area/IndicationsDiabetic Nephropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndonesia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesPT. JES Kasih Nusantara Sejahterah

China Registration ClassN/A

Develop Information

Active CompaniesPT. JES Kasih Nusantara Sejahterah

Inactive CompaniesN/A

Active IndicationsDiabetic Nephropathies

Inactive IndicationsN/A

Other Information

ATC CodeN/A